# STOCKHOLM 1.0
#=GF ID   TERT_C
#=GF AC   PF21399.1
#=GF DE   Telomerase reverse transcriptase, C-terminal extension
#=GF AU   Bateman A;0000-0002-6982-4660
#=GF AU   Lazaro Pinto Beatriz;0000-0001-6837-2941
#=GF SE   ECOD:EF24800
#=GF GA   27.00 27.00;
#=GF TC   27.00 27.00;
#=GF NC   26.90 26.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Domain
#=GF RC   Paper describing PDB structure 5ugw
#=GF RN   [1]
#=GF RM   28154186
#=GF RT   Structural Analysis Reveals the Deleterious Effects of
#=GF RT   Telomerase Mutations in Bone Marrow Failure Syndromes.
#=GF RA   Hoffman H, Rice C, Skordalakes E;
#=GF RL   J Biol Chem. 2017;292:4593-4601.
#=GF RC   Paper describing PDB structure 7bg9
#=GF RN   [2]
#=GF RM   33883742
#=GF RT   Structure of human telomerase holoenzyme with bound telomeric
#=GF RT   DNA.
#=GF RA   Ghanim GE, Fountain AJ, van Roon AM, Rangan R, Das R, Collins K,
#=GF RA   Nguyen THD;
#=GF RL   Nature. 2021;593:449-453.
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   This domain is found at the C-terminal end of Telomerase reverse
#=GF CC   transcriptase (TERT), a ribonucleoprotein enzyme essential for
#=GF CC   the replication of chromosome termini in most eukaryotes. This
#=GF CC   entry represents the C-terminal extension (also known as the
#=GF CC   thumb  domain), which forms an all helical bundle. There are
#=GF CC   three conserved motifs in this domain involved in nucleic acid
#=GF CC   binding. In humans, single mutations localised within this
#=GF CC   portion of telomerase are associated with several bone marrow
#=GF CC   failure syndromes [1,2].
#=GF SQ   8
#=GS TERT_HUMAN/968-1097         AC O14746.1
#=GS L9LC90_TUPCH/912-1041       AC L9LC90.1
#=GS A0A1A6GV63_NEOLE/1163-1292  AC A0A1A6GV63.1
#=GS A0A093GIQ6_DRYPU/1163-1292  AC A0A093GIQ6.1
#=GS K7G1G5_PELSI/1092-1221      AC K7G1G5.1
#=GS A0A0D2UNU5_CAPO3/1020-1146  AC A0A0D2UNU5.1
#=GS G1PKR5_MYOLU/932-1061       AC G1PKR5.1
#=GS S9XPE4_CAMFR/796-925        AC S9XPE4.1
TERT_HUMAN/968-1097                    RNMRRKLFGVLRLKCHSLFLDLQVNSLQTVCTNIYKILLLQAYRFHACVLQLPFHQQVWKNPTFFLRVISDTASLCYSILKAKNAGMSLGAKGAAGPLPSEAVQWLCHQAFLLKLTRHRVTYVPLLGSLR
L9LC90_TUPCH/912-1041                  RALRRKLFGVLRLKCHGIFLDLQVNSLQTVCVNVYKVLLLQAYRFHACVLQLPFDQQVHKNPPFFLRVISDTASLCYSILRARSAGVTLGTRGAGGPFPFEAAEWLCVHAFLHKLARHPCTYSTLLGTLR
A0A1A6GV63_NEOLE/1163-1292             RKMQQKLLALLRLKCHGLFLDLQVNSLQTVCINVYKIFLLQAYRFHACVLQLPFDQHVRKNPAFFLGIIFSMTSCCYSILKVKNAGMTLKTKGASGLFPPEAVCWLCYRAFLCKLAGHSVIYKRLLGTLR
A0A093GIQ6_DRYPU/1163-1292             KNMKYKLIAVLRLKCHGLFLDLQINSLQTVLLNIYKIFLLQACRFHACVLQLPFNQKVRNNPDFFLRIISQTASCCYATVKAKNAGFALGTKGVSDIFPFEAAEWLCYHAFTVKLSKYRIIYKCLLKPLK
K7G1G5_PELSI/1092-1221                 KNMKYKLVAVLKLKCHSLFLDLQINTLQTVFINIYKIFLLQAYRFHACVLQLPFNQQVRNNPCFFLRIISGSASCCYSILKTKNAGIALGTKGASGPFPSEAAEWLCYHAFIIKLTKHKVVYKCLLKPLK
A0A0D2UNU5_CAPO3/1020-1146             RSLRHKMIQSLKPKCHAMLLDCRLNTLLDVQVNVYQIFLLSAIKFHCIVRELPASRRVQGNPAFFIELVLESISFFYSLIQTKTQGVALPVQC...SLTRRQVMWIGCHAFITILERKQTDYAPLLRGLT
G1PKR5_MYOLU/932-1061                  RSMRRKLFAVLRLKCHSLLLDLQVNGLQTVCTNVYKIFLLQAYRFHACVLQLPFNQHVRKNPSFFLRVISDTASRCHTLLKAKNPGMPLGTKGAAGPFPSEAARWLCFHAFLLKLSRHSATYRCLLGALQ
S9XPE4_CAMFR/796-925                   RNMRRKLFAVLRLKCHGLFLDLQVNSLQTVFTNVYKIFLLQAYRFHACVLQLPFNQPVRRNPAFFLRVVSDTASRAYSLLKARNSGTSLGAQGASGPFPLEAAQWLCLHAFRLKLAGHHITYSCLLGPLR
#=GC seq_cons                          RsMR+KLhAVLRLKCHuLFLDLQVNSLQTVplNVYKIFLLQAYRFHACVLQLPFsQpVR+NPsFFLRlIS-TASpCYSlLKAKNAGhuLGTKGAuGPFP.EAApWLCaHAFllKLu+HplsYpsLLGsL+
